SCHEMBL20049905

SCHEMBL20049905

C=C(C)Nc1ncc(-c2cccnc2)cc1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 1/20 0.44
MKNK2 Q9HBH9 1/20 0.44
PDGFRB P09619 2/20 0.43
PDGFRA P16234 2/20 0.43
EGFR P00533 1/20 0.43
CYP2A6 P11509 6/20 0.42
GRM5 P41594 1/20 0.42
CYP3A4 P08684 2/20 0.42
CYP1A2 P05177 2/20 0.42
ALDH1A1 P00352 1/20 0.42
SLC2A1 P11166 1/20 0.41
CYP11B2 P19099 2/20 0.41
DYRK1A Q13627 1/20 0.40
DYRK1B Q9Y463 1/20 0.40
CYP2E1 P05181 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2B6 P20813 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAPK10 P53779 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20049886 0.85 PSMB5 (0.42) MKNK2GRM5GSK3AGSK3B
SCHEMBL20049970 0.81 GRM5 (0.43) PDGFRBPDGFRAGRM5ALDH1A1GSK3A
SCHEMBL25588074 0.80 CHRNA7 (0.38) PDGFRBPDGFRAGRM5CYP1A2ALDH1A1
SCHEMBL20049984 0.80 ESR2 (0.47) GRM5
SCHEMBL25588429 0.78 GRIN1 (0.35) ALDH1A1
SCHEMBL20049992 0.77 CNR1 (0.39) CYP3A4CYP1A2ALDH1A1CYP2D6CYP2C19
SCHEMBL20049908 0.77 CYP1A2 (0.40) CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL20049775 0.77 NPC1 (0.42) PDGFRBPDGFRAALDH1A1
SCHEMBL20049842 0.76 NEK1 (0.43) GRM5GSK3A
SCHEMBL20049967 0.76 ALDH1A1 (0.52) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018067786-A1 SUBSTITUTED 1H-IMIDAZO[4,5-B]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-04-12 WO disclosed